Ischemic preconditioning and morphine induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 8, 1997, Pages 2187-2195

  Schultz, JoEl J ^a   Hsu, Anna K ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Ischemic preconditioning; Morphine; Myocardial protection; Naltrindole; opioid receptors

Indexed keywords

DELTA OPIATE RECEPTOR; MORPHINE; NALTRINDOLE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; HEART; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; TISSUE PRESERVATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031214687     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0454     Document Type: Article

References (67)

1. AKIL H, WATSON SJ, YOUNG ME, KHACHATURIAN H, WALKER JM, 1984. Endogenous opioids: biology and function. Ann Rev Neurosci 7: 223-255.
2. 1-adrenergic mechanism. Circ Res 73: 656-670.
3. BARRON BA, GU H, GAUGL JF, CAFFREY JL, 1992. Screening for opioids in dog heart. J Mol Cell Cardiol 24: 67-77.
4. BOLUYT MO, YOUNES A, CAFFREY JL, O'NEILL L, BARRON BA, CROW MT, LAKATTA EG, 1993. Age-associated increase in rat cardiac opioid production. Am J Physiol 265: H212-H218.
5. BUGGE E, YTREHUS K, 1995. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of a adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 29: 401-406.
6. CAFFREY JL, BOLUYT MO, YOUNES A, BARRON BA, O'NEILL L, CROW MT, LAKATTA EG, 1994. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J Mol Cell Cardiol 26: 701-711.
7. CHIEN GL, VAN WINKLE DM, 1996. Naloxone blockade of myocardial ischemic preconditioning is stereo-selective. J Mol Cell Cardiol 28: 1895-1900.
8. 5]-enkephalin). J Thorac Cardiovascular Surg 107: 964-967.
9. CHILDERS SR, 1991. Opioid receptor-coupled second messenger systems. Life Sci 48: 1991-2003.
10. CLEMENT-JONES V, LOWRY P, REES LH, BESSER GM, 1980. Met-enkephalin circulates in human plasma. Nature 283: 295-297.
11. Cox BM, 1993. Opioid receptor-G protein interactions: acute and chronic effects of opioids. In: Herz A (ed.). Handbook of Experimental Pharmacology: Opioids I. New York: Springer-Verlag, 145-188.
12. FLEMINGER G, HOWELLS RD, KILPATRICK DL, UDENFRIEND S, 1984. Intact proenkephalin is the major enkephalin-containing peptide produced in rat adrenal glands after denervation. Proc Natl Acad Sci USA 81: 7985-7988.
13. GOLDSTEIN A, JAMES IF, 1984. Multiple opioid receptors: criteria for identification and classification. Trends Pharmacol Sci 5: 503-505.
14. GUILLEMIN R, VARGO TM, ROSSIER J, MINICK S, LING N, RIVIER C, 1977. Beta-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland. Science 197: 1367-1369.
15. HEADRICK JP, 1996. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 28: 1227-1240.
16. HOWELLS RD, KILPATRICK DL, BAILEY LC, NOE M, UDENFRIEND S, 1986. Proenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 83: 1960-1963.
17. 1b-adrenoreceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 92: 2259-2265.
18. + channel. Biochem Biophys Res Comm 208: 302-308.
19. JIANG Q, MOSBERG HI, PORRECA F, 1986. Modulation of the potency of mu-mediated antinociception by delta agonists in the mouse. J Pharmacol Exp Ther 254: 683-689.
20. 6]enkephalin and naltrindole 5-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther 257: 1069-1075.
21. KLEIN HH, PUSCHMANN S, SCHAPER J, SCHAPER W, 1981. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch 393: 287-297.
22. KRUMINS SA, DADEN AI, FEURESTEIN G, 1985. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Comm 127: 120-128.
23. LANG RE, HERMAN K, DIETZ R, GAIDA W, GANTEN D, KRAFT K, UNGER T, 1983. Evidence for the presence of enkephalins in the heart. Life Sci 32: 399-406.
24. LAUGWITZ K-L, OFFERMANNS S, SPICHER K, SCHULTZ G, 1993. μ-and δ-opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 10: 233-242.
25. LEWIS RL, STERN AS, KILPATRICK DL, GERBER LD, ROSSIER J, STEIN S, UDENFRIEND S, 1981. Marked increases in larger enkephalin-containing polypeptides in the rat adrenal gland following denervation. J Neurosci 1: 80-82.
26. LI Y, KLONER RA, 1993. The cardioprotective effects of ischemic preconditioning are not mediated by adenosine receptors in rat hearts. Circulation 87: 1642-1648.
27. LIU Y, DOWNEY JM, 1992. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263: H1107-H1112.
28. LORD JAH, WATERFIELD AA, HUGHES J, KOSTERLITZ HW, 1977. Endogenous opioid peptides: multiple agonists and receptors. Nature 267: 495-500.
29. LOW KG, ALLEN RG, MELNER MH, 1990. Association of proenkephalin transcripts with polyribosomes in the heart. Mol Endocrinol 4: 1408-1415.
30. MANNHEIMER C, EMANUELSSON H, LARSSON G, WAAGSTEIN F, AUGUSTINSSON L-E, ELIASSON T, 1991. Myocardial release of endogenous opioids in the human heart and the effects of epidural spinal electrical stimulation (ESES) in pacing-induced angina pectoris (Abstract). J Am Coll Cardiol 17: 107A.
31. MANTELLI L, CORTI V, LEDDA F, 1987. On the presence of opioid receptors in guinea-pig ventricular tissue. Gen Pharmacol 18: 309-311.
32. MARTIN WR, 1983. Pharmacology of opioids. Pharmacol Rev 35: 283-323.
33. 2] deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther 258: 583-587.
34. MAYFIELD KP, D'ALECY LG, 1994a. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther 268: 74-77.
35. MAYFIELD KP, D'ALECY LG, 1994b. Delta-1 opioid dependence of acute hypoxic adaptation. J Pharmacol Exp Ther 268: 74-77.
36. MELDRUM DR, CLEVELAND JC, SHERIDAN BC, ROWLAND RT, BANERJEE A, HARKEN AH, 1996. Differential effects of adenosine preconditioning on the postischemic rat myocardium. J Surg Res 65: 159-164.
37. MIKI T, DOWNEY J, 1996. Opioid receptors participate in ischemic preconditioning in rabbits (Abstract). J Mol Cell Cardiol 28: A187.
38. MILLER RJ, 1982. Multiple opiate receptors for multiple opioid peptides. Med Biol 60: 1-6.
39. MURA RA, NIROOMAND F, 1996. Delta and kappa selective opioid agonist inhibit adenylyl cyclase activity through activation of Gi proteins in cardiac sarcolemma (Abstract). Circulation 94: 1-474.
40. NORTH RA, 1986. Opioid receptor types and membranes ion channels. Trends Neurosci 9: 114-117.
41. NORTH RA, WILLIAMS JT, SURPRENANT A, CHRISTIE MJ, 1987. μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84: 5487-5491.
42. PARADIS P, DUMONT M, BELICHARD P, ROULEAU J-L, LEMAIRE S, BRAKIER-GINGRAS L, 1992. Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction. Biochem Cell Biol 70: 593-598.
43. PATERSON SJ, ROBSON LE, KOSTERLITZ HW, 1983. Classification of opioid receptors. Br Med Bull 39: 1-36.
44. PORTOGHESE PS, SULTANA M, TAKEMORI AE, 1988. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol 146: 185-186.
45. PORTOGHESE PS, SULTANA M, TAKEMORI AE, 1990. Design of peptidomimetic δ opioid receptor antagonists using the message-address concept. J Med Chem 33: 1714-1720.
46. ATP channel in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am J Physiol 271: H23-H28.
47. 125I]β-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex. J Pharmacol Exp Ther 253: 419-426.
48. SCHULTZ JJ, ROSE E, YAO Z, GROSS GJ, 1995. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268: H2157-H2161.
49. SCHULTZ JJ, HSU AK, GROSS GJ, 1996. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100-1104.
50. SCHULTZBERG M, HOKFELT T, TERENIUS L, ELFVIN L-G, LUNDBERG JM, BRANDT J, ELDE RP, GOLDSTEIN M, 1979. Enkephalin immunoreactive nerve fibers and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience 4: 249-270.
51. + channels. Am J Physiol 269: H997-H1002.
52. 5]-enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. J Pharmacol Exp Ther 249: 462-469.
53. SOFUOGLU M, PORTOGHESE PS, TAKEMORI AE, 1991. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257: 676-680.
54. SPRINGHORN JP, CLAYCOMB EC, 1989. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 258: 73-78.
55. SPRINGHORN JP, CLAYCOMB WC, 1992. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol 63: H1560-H1566.
56. 3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol 23: 1297-1302.
57. TRAYNOR JR, ELLIOTT J, 1993. δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol Sci 14: 84-86.
58. VENTURA C, BASTAGLI L, BERNARDI P, CALDARERA CM, GUARNIERI C, 1989. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 987: 69-74.
59. VIVEROS OH, DILIBERTO JR EJ, HONG JS, KIZER JS, UNSWORTH CD, KANAMATSU T, 1987. The regulation of enkephalin levels in adrenomedullary cells and relation to chromaffin vesicle biogenesis and functional plasticity. Ann NY Acad Sci 493: 324-341.
60. WESELCOUCH EO, BAIRD AJ, SLEPH PG, DZWONCZYK S, MURRAY HN, GROVER GJ, 1995. Endogenous catecholamines are not necessary for ischemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 29: 126-132.
61. WILD KD, VANDERAH T, MOSBERG HI, PORRECA F, 1991. Opioid δ receptor subtypes are associated with different potassium channels. Eur J Pharmacol 193: 135-136.
62. WILLIAMS JT, EGAN TM, NORTH RA, 1982. Enkephalin opens potassium channels on mammalian central neurones. Nature 299: 74-77.
63. WINTER CB, CLEVELAND JC, BUTLER KL, BENSARD DB, MITCHELL MB, HARKEN AH, BANERJEE A, 1997. Facilitative interactions between noradrenergic and purinergic signaling during preconditioning of the rat heart. J Mol Cell Cardiol 29: 163-173.
64. XIAO R-P, PEPE S, SPURGEON HA, CAPOGROSSI MC, LAKATTA EG, 1997. Opioid peptide receptor stimulation reverses β-adrenergic effects in rat heart cells. Am J Physiol 272: H797-H805.
65. YANG H-YT, HEXUM T, COSTA E, 1980. Opioid peptides in adrenal gland. Life Sci 27: 1119-1125.
66. ZHANG W-M, JIN W-Q, WONG TM, 1996. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 28: 1547-1554.
67. ZIMLICHMAN R, GEFEL D, ELIAHOU H, MATAS Z, ROSEN B, GASS S, ELA C, EILAM Y, VOGEL Z, BARG J, 1996. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93: 1020-1025.